Device Tech wins NSW Health's defib rollout contract


Monday, 22 August, 2022

Device Tech wins NSW Health's defib rollout contract

Following a tender and evaluation process, Device Technologies Australia has been contracted by NSW Health to roll out patient monitors and touch-screen defibrillators.

Device Technologies will work with eHealth NSW, NSW Ambulance and local health districts to implement 1400 devices, as well as an associated ECG notification platform. The platform enables real-time connectivity between ambulances, hospitals and specialists for continuous patient monitoring.

Mick Trevaskis, Device Technologies CEO, said, “We’re pleased to partner with NSW Health to deliver this future-ready solution to ambulances and health sites across the state. We have represented corpuls in Australia for over 10 years and during that time have worked to roll out the technology across Queensland, Western Australia and South Australian Ambulance Services.”

A comprehensive tender process and evaluation was undertaken to ensure the solution met the needs of healthcare professionals using it, as well as the needs of patients from the incident site to the hospital and throughout the continuum of care.

NSW Ambulance Chief Executive Dr Dominic Morgan said ECGs are a crucial tool for NSW Ambulance in supporting patients with suspected Acute Coronary Syndrome — a group of conditions caused by reduced blood flow to the heart.

The input from currently practising clinicians has been invaluable in this process and has helped shape what clinical practice will look like with this new device and clinical data notification platform, Dr Morgan said.

“NSW Health has taken full advantage of the innovative technology available in defibrillation and patient monitoring. We are looking forward to working alongside our trusted partner, Device Technologies Australia, to support NSW Health,” said Michael Heller, Vice President, corpuls.

The rollout of the device and connectivity technology is expected to commence in late-2022.

Image: Supplied.

Related News

US case highlights dangers of fentanyl inhalation

The lead author of the study said it should be taken as a warning about the danger of a substance...

Project to review virtual EDs across five states

As hospitals battle ramping challenges, alternative virtual EDs have been seen as one solution to...

Alfred Health trials eye-tracking tech to assess brain function

The Alfred hospital has commenced clinical trials with BrainEye to screen for neurological...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd